U.S. Drug Retail Industry Analysis
UpdatedMay 28, 2022
DataAggregated Company Financials
Companies8
- 7D6.7%
- 3M-5.4%
- 1Y-19.5%
- YTD-17.7%
In the last week, the Drug Retail industry is up 6.7%, with all of the companies up. However, the industry is down 19% over the past year. In the next few years, earnings are forecast to decline by 9.3% annually.
Industry Valuation and Performance
Has the U.S. Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Sun, 29 May 2022 | US$38.0b | US$138.0b | US$5.8b | 6.4x |
| Tue, 26 Apr 2022 | US$39.7b | US$138.1b | US$5.8b | 47.5x |
| Thu, 24 Mar 2022 | US$41.2b | US$161.5b | US$5.6b | 6.8x |
| Sat, 19 Feb 2022 | US$41.1b | US$161.4b | US$5.6b | 6.7x |
| Mon, 17 Jan 2022 | US$47.9b | US$161.4b | US$5.6b | 7.9x |
| Wed, 15 Dec 2021 | US$43.5b | US$158.8b | US$1.7b | 21.4x |
| Fri, 12 Nov 2021 | US$44.5b | US$158.7b | US$1.7b | 21.7x |
| Sun, 10 Oct 2021 | US$42.3b | US$172.3b | US$2.0b | 18.2x |
| Tue, 07 Sep 2021 | US$45.9b | US$172.2b | US$2.1b | 19.6x |
| Thu, 05 Aug 2021 | US$41.5b | US$148.0b | US$2.1b | 18x |
| Sun, 09 May 2021 | US$47.5b | US$144.1b | -US$775,834,974.59 | n/a |
| Wed, 10 Feb 2021 | US$44.8b | US$142.5b | -US$824,820,977.24 | n/a |
| Tue, 03 Nov 2020 | US$30.1b | US$140.7b | US$373.2m | 37.5x |
| Fri, 07 Aug 2020 | US$35.9b | US$126.5b | US$416.7m | 37.1x |
| Thu, 30 Apr 2020 | US$39.5b | US$152.5b | US$2.8b | 11.4x |
| Sun, 02 Feb 2020 | US$46.2b | US$155.3b | US$3.1b | 188.6x |
| Wed, 06 Nov 2019 | US$49.8b | US$159.0b | US$3.4b | 12.3x |
| Sat, 10 Aug 2019 | US$50.0b | US$158.5b | US$4.0b | 17.3x |
Median PE Ratio
9.4x
Current Industry PEThere is only one profitable company in this industry, so there is insufficient data to make an industry-wide assessment of PE.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 12% per year over the last three years.
- Meanwhile revenues for these companies have declined 4.5% per year.
- This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.
Industry Comparison
How does U.S. Drug Retail compare with similar industries?
| US Market | 5.92% | |
| Consumer Staples | 6.32% | |
| Food and Staples Retail | 9.40% | |
| Drug Retail | 6.75% | |
| Big Box Super Stores | 9.68% | |
| Food Distributors | 9.37% | |
| Food Retail | 8.68% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| WBA Walgreens Boots Alliance | US$43.71 | 6.7% +US$2.4b | -17.0% | PS6.4x | |
| YI 111 | US$1.92 | 20.8% +US$27.5m | -80.3% | PS0.09x | |
| RAD Rite Aid | US$5.75 | 2.3% +US$7.2m | -68.5% | PS0.01x | |
| MDVL MedAvail Holdings | US$1.71 | 1.2% +US$1.4m | -86.7% | PS4.4x | |
| CJJD China Jo-Jo Drugstores | US$1.99 | 2.1% +US$139.2k | -83.3% | PS0.05x |